Surrozen Inc

XNAS:SRZN

19.00

-0.45 (-2.31%)

7:30:07 PM EDT: $19.00 0.00 (0.00%)

Market Cap (Intraday)	218.16M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.47 Million
Adjusted EPS	-$1.10

See more estimates

10-Day MA	$21.09
50-Day MA	$22.45
200-Day MA	$24.21

See more pivots

Surrozen Inc Stock, XNAS:SRZN

171 Oyster Point Boulevard, Suite 400, South San Francisco, California 94080

United States of America

Phone: +1.650.489.9000

Number of Employees: 42

http://www.surrozen.com

Description

Surrozen, Inc. is a clinical stage biotechnology company. It engages in the business of discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. The company was founded by K. Christopher Garcia and Roeland Nusse on August 12, 2015 and is headquartered in South San Francisco, CA.